These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 7835795

  • 1. Second-look laparotomy in ovarian cancer.
    Creasman WT.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L, Brunetto VL, Yordan E, DiSaia PJ, Creasman WT.
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [Abstract] [Full Text] [Related]

  • 6. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP.
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the role of second-look surgery in ovarian cancer.
    Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE.
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
    [Abstract] [Full Text] [Related]

  • 10. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A, Sevelda P.
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [Abstract] [Full Text] [Related]

  • 11. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC.
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
    Williams L.
    Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A formula for predicting the risk of a positive second-look laparotomy in epithelial ovarian cancer: implications for a randomized trial.
    Morgan MA, Noumoff JS, King S, Mikuta JJ.
    Obstet Gynecol; 1992 Dec; 80(6):944-8. PubMed ID: 1333064
    [Abstract] [Full Text] [Related]

  • 18. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 19. Results of second-look laparotomy in patients with early-stage ovarian carcinoma.
    Walton L, Ellenberg SS, Major F, Miller A, Park R, Young RC.
    Obstet Gynecol; 1987 Nov; 70(5):770-3. PubMed ID: 3658289
    [Abstract] [Full Text] [Related]

  • 20. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.